B6Brd;B6N-Tyrc-Brd Ftotm1a(EUCOMM)Wtsi/WtsiCnbc

Status

Available to order

EMMA IDEM:05094
International strain nameB6Brd;B6N-Tyrc-Brd Ftotm1a(EUCOMM)Wtsi/WtsiCnbc
Alternative nameEPD0103_5_A10
Strain typeTargeted Mutant Strains
Allele/Transgene symbolFtotm1a(EUCOMM)Wtsi
Gene/Transgene symbolFto
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0103_5_A10. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
References
  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (allele matching)
  • decreased circulating alanine transaminase level / IMPC
  • decreased circulating iron level / IMPC
  • decreased circulating cholesterol level / IMPC
IMPC phenotypes (gene matching)
  • decreased circulating cholesterol level / IMPC
  • decreased circulating iron level / IMPC
  • decreased circulating alanine transaminase level / IMPC
MGI phenotypes (allele matching)
  • decreased circulating LDL cholesterol level / MGI
  • hyperactivity / MGI
  • decreased circulating alanine transaminase level / MGI
  • decreased circulating iron level / MGI
  • decreased lactate dehydrogenase level / MGI
  • decreased circulating aspartate transaminase level / MGI
MGI phenotypes (gene matching)
  • decreased bone mineral density / MGI
  • decreased circulating LDL cholesterol level / MGI
  • dermatitis / MGI
  • decreased body length / MGI
  • decreased body weight / MGI
  • hyperactivity / MGI
  • hypoactivity / MGI
  • abnormal eating behavior / MGI
  • polyphagia / MGI
  • increased circulating triglyceride level / MGI
  • increased circulating HDL cholesterol level / MGI
  • postnatal growth retardation / MGI
  • increased circulating glucagon level / MGI
  • decreased circulating insulin level / MGI
  • decreased circulating alanine transaminase level / MGI
  • increased lean body mass / MGI
  • decreased lean body mass / MGI
  • decreased circulating iron level / MGI
  • decreased circulating insulin-like growth factor I level / MGI
  • increased energy expenditure / MGI
  • cachexia / MGI
  • increased circulating cholesterol level / MGI
  • abnormal metabolism / MGI
  • abnormal oxygen consumption / MGI
  • increased oxygen consumption / MGI
  • improved glucose tolerance / MGI
  • homeostasis/metabolism phenotype / MGI
  • growth/size/body region phenotype / MGI
  • abnormal circulating hormone level / MGI
  • decreased percent body fat/body weight / MGI
  • increased circulating glucose level / MGI
  • decreased lactate dehydrogenase level / MGI
  • decreased circulating aspartate transaminase level / MGI
  • increased susceptibility to diet-induced obesity / MGI
  • decreased susceptibility to diet-induced obesity / MGI
  • increased circulating adrenaline level / MGI
  • decreased circulating leptin level / MGI
  • increased circulating leptin level / MGI
  • abnormal carbon dioxide production / MGI
  • increased carbon dioxide production / MGI
  • decreased carbon dioxide production / MGI
  • increased basal metabolism / MGI
  • decreased white fat cell size / MGI
  • decreased gonadal fat pad weight / MGI
  • increased total body fat amount / MGI
  • decreased total body fat amount / MGI
  • increased respiratory quotient / MGI
  • decreased respiratory quotient / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • preweaning lethality, incomplete penetrance / MGI
  • abnormal urine catecholamine level / MGI
  • increased food intake / MGI

Literature references

  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131
  • The Role of m6A/m-RNA Methylation in Stress Response Regulation.;Engel Mareen, Eggert Carola, Kaplick Paul M, Eder Matthias, Röh Simone, Tietze Lisa, Namendorf Christian, Arloth Janine, Weber Peter, Rex-Haffner Monika, Geula Shay, Jakovcevski Mira, Hanna Jacob H, Leshkowitz Dena, Uhr Manfred, Wotjak Carsten T, Schmidt Mathias V, Deussing Jan M, Binder Elisabeth B, Chen Alon, ;2018;Neuron;99;389-403.e9; 30048615

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).